Soft Tissue Sarcoma — Trials

Soft Tissue Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

1,383 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 338
Recruiting: 188
Ph III recruiting: 14
Growth YoY: −16.5%
Industry share: 14%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (195)

clinicaltrialsPublishedShowing 51–57 of 57 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01795430	Whole-Body Radiation Therapy, Systemic Chemotherapy, and High-Dose Chemotherapy Followed By Stem Cell Rescue in Treating Patients With Poor-Risk Ewing Sarcoma	withdrawn	N/A	0	City of Hope Medical CenterOTHER	1	Jan 9, 2015	clinicaltrials
NCT00874302	Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms	withdrawn	Phase 3	0	Repros Therapeutics Inc.INDUSTRY	2	Jun 27, 2014